These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Efficacy and safety of implantable cardioverter-defibrillators in patients with Chagas disease. Barbosa MP; da Costa Rocha MO; de Oliveira AB; Lombardi F; Ribeiro AL Europace; 2013 Jul; 15(7):957-62. PubMed ID: 23376978 [TBL] [Abstract][Full Text] [Related]
63. Mechanisms and management of inappropriate therapy in subcutaneous implantable cardioverter defibrillators. Karnik AA; Helm RH; Monahan KM J Cardiovasc Electrophysiol; 2019 Mar; 30(3):402-409. PubMed ID: 30576031 [TBL] [Abstract][Full Text] [Related]
64. Implantable cardiac electronic device therapy for patients with a systemic right ventricle. Barracano R; Brida M; Guarguagli S; Palmieri R; Diller GP; Gatzoulis MA; Wong T Heart; 2020 Jul; 106(14):1052-1058. PubMed ID: 32269130 [TBL] [Abstract][Full Text] [Related]
65. Role of CMR imaging in risk stratification for sudden cardiac death. Aljaroudi WA; Flamm SD; Saliba W; Wilkoff BL; Kwon D JACC Cardiovasc Imaging; 2013 Mar; 6(3):392-406. PubMed ID: 23473115 [TBL] [Abstract][Full Text] [Related]
66. Should an implanted defibrillator be considered in patients with vasospastic angina? Eschalier R; Souteyrand G; Jean F; Roux A; Combaret N; Saludas Y; Clerfond G; Barber-Chamoux N; Citron B; Lusson JR; Brugada P; Motreff P Arch Cardiovasc Dis; 2014 Jan; 107(1):42-7. PubMed ID: 24373622 [TBL] [Abstract][Full Text] [Related]
67. Genetic profiling as a marker for risk of sudden cardiac death. Gollob MH Curr Opin Cardiol; 2006 Jan; 21(1):42-6. PubMed ID: 16355028 [TBL] [Abstract][Full Text] [Related]
69. The merits of the ICD for inherited heart rhythm disorders: A critical re-appraisal. Roston TM; Krahn AD; Ong K; Sanatani S Trends Cardiovasc Med; 2020 Oct; 30(7):415-421. PubMed ID: 31685385 [TBL] [Abstract][Full Text] [Related]
70. End-of-life of implantable defibrillator: are we certain it should always be replaced? Stazi F J Cardiovasc Med (Hagerstown); 2018 Feb; 19 Suppl 1():e116-e119. PubMed ID: 29538158 [No Abstract] [Full Text] [Related]
71. Cardiac defibrillation and resynchronization therapies: principles, therapies, and management implications. Bubien RS; Ching EA; Kay GN AACN Clin Issues; 2004; 15(3):340-61. PubMed ID: 15475810 [TBL] [Abstract][Full Text] [Related]
72. Device therapy: Who may and who may not benefit from an ICD? Pinter A; Dorian P Nat Rev Cardiol; 2011 Jan; 8(1):10-2. PubMed ID: 21079640 [No Abstract] [Full Text] [Related]
73. ICD implantation for secondary prevention in patients with ventricular arrhythmia in the setting of acute cardiac ischemia and a history of myocardial infarction. van Dijk VF; Quast ABE; Schaap J; Balt JC; Kelder JC; Wijffels MCEF; de Groot JR; Boersma LVA J Cardiovasc Electrophysiol; 2020 Feb; 31(2):536-543. PubMed ID: 31944462 [TBL] [Abstract][Full Text] [Related]
74. Left Ventricular Dilatation Increases the Risk of Ventricular Arrhythmias in Patients With Reduced Systolic Function. Aleong RG; Mulvahill MJ; Halder I; Carlson NE; Singh M; Bloom HL; Dudley SC; Ellinor PT; Shalaby A; Weiss R; Gutmann R; Sauer WH; Narayanan K; Chugh SS; Saba S; London B J Am Heart Assoc; 2015 Jul; 4(8):e001566. PubMed ID: 26231842 [TBL] [Abstract][Full Text] [Related]
75. Device Therapies Among Patients Receiving Primary Prevention Implantable Cardioverter-Defibrillators in the Cardiovascular Research Network. Greenlee RT; Go AS; Peterson PN; Cassidy-Bushrow AE; Gaber C; Garcia-Montilla R; Glenn KA; Gupta N; Gurwitz JH; Hammill SC; Hayes JJ; Kadish A; Magid DJ; McManus DD; Multerer D; Powers JD; Reifler LM; Reynolds K; Schuger C; Sharma PP; Smith DH; Suits M; Sung SH; Varosy PD; Vidaillet HJ; Masoudi FA J Am Heart Assoc; 2018 Mar; 7(7):. PubMed ID: 29581222 [TBL] [Abstract][Full Text] [Related]
76. The interplay between CKD, sudden cardiac death, and ventricular arrhythmias. Pun PH Adv Chronic Kidney Dis; 2014 Nov; 21(6):480-8. PubMed ID: 25443573 [TBL] [Abstract][Full Text] [Related]